The RSI Oscillator for CHE moved out of oversold territory on September 25, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 22 similar instances when the indicator left oversold territory. In 14 of the 22 cases the stock moved higher. This puts the odds of a move higher at 64%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 30 of 59 cases where CHE's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 51%.
The Momentum Indicator moved above the 0 level on October 14, 2026. You may want to consider a long position or call options on CHE as a result. In 45 of 91 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 49%.
The Moving Average Convergence Divergence (MACD) for CHE just turned positive on October 14, 2026. Looking at past instances where CHE's MACD turned positive, the stock continued to rise in 29 of 53 cases over the following month. The odds of a continued upward trend are 55%.
Following a +2.93% 3-day Advance, the price is estimated to grow further. Considering data from situations where CHE advanced for three days, in 162 of 326 cases, the price rose further within the following month. The odds of a continued upward trend are 50%.
CHE moved below its 50-day moving average on September 10, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for CHE crossed bearishly below the 50-day moving average on September 11, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 8 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 57%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CHE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 49%.
The Aroon Indicator for CHE entered a downward trend on October 05, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 12 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.091) is normal, around the industry mean (208.195). P/E Ratio (25.870) is within average values for comparable stocks, (175.456). Projected Growth (PEG Ratio) (1.876) is also within normal values, averaging (2.498). Dividend Yield (0.005) settles around the average of (0.005) among similar stocks. P/S Ratio (2.714) is also within normal values, averaging (2.688).
The Tickeron PE Growth Rating for this company is 30 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 36 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 42 (best 1 - 100 worst), indicating steady price growth. CHE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Profit vs. Risk Rating rating for this company is 87 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CHE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock worse than average.
The 10-day moving average for OPCH crossed bullishly above the 50-day moving average on October 07, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 75%.
The Momentum Indicator moved above the 0 level on October 06, 2026. You may want to consider a long position or call options on OPCH as a result. In 60 of 97 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 62%.
The Moving Average Convergence Divergence (MACD) for OPCH just turned positive on October 06, 2026. Looking at past instances where OPCH's MACD turned positive, the stock continued to rise in 24 of 47 cases over the following month. The odds of a continued upward trend are 51%.
OPCH moved above its 50-day moving average on October 06, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +0.39% 3-day Advance, the price is estimated to grow further. Considering data from situations where OPCH advanced for three days, in 177 of 295 cases, the price rose further within the following month. The odds of a continued upward trend are 60%.
The Aroon Indicator entered an Uptrend today. In 153 of 217 cases where OPCH Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 71%.
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 7 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where OPCH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 65%.
OPCH broke above its upper Bollinger Band on October 06, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Price Growth Rating for this company is 37 (best 1 - 100 worst), indicating steady price growth. OPCH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 53 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 65 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 70 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.723) is normal, around the industry mean (208.195). P/E Ratio (17.348) is within average values for comparable stocks, (175.456). Projected Growth (PEG Ratio) (1.101) is also within normal values, averaging (2.498). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (0.682) is also within normal values, averaging (2.688).
The Tickeron Profit vs. Risk Rating rating for this company is 77 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OPCH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock better than average.
CHE | OPCH | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 18 | 47 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 12 Undervalued | 70 Overvalued | |
PROFIT vs RISK RATING 1..100 | 87 | 77 | |
SMR RATING 1..100 | 36 | 53 | |
PRICE GROWTH RATING 1..100 | 42 | 37 | |
P/E GROWTH RATING 1..100 | 30 | 65 | |
SEASONALITY SCORE 1..100 | 85 | 75 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
CHE's Valuation (12) in the Medical Or Nursing Services industry is somewhat better than the same rating for OPCH (70) in the null industry. This means that CHE’s stock grew somewhat faster than OPCH’s over the last 12 months.
OPCH's Profit vs Risk Rating (77) in the null industry is in the same range as CHE (87) in the Medical Or Nursing Services industry. This means that OPCH’s stock grew similarly to CHE’s over the last 12 months.
CHE's SMR Rating (36) in the Medical Or Nursing Services industry is in the same range as OPCH (53) in the null industry. This means that CHE’s stock grew similarly to OPCH’s over the last 12 months.
OPCH's Price Growth Rating (37) in the null industry is in the same range as CHE (42) in the Medical Or Nursing Services industry. This means that OPCH’s stock grew similarly to CHE’s over the last 12 months.
CHE's P/E Growth Rating (30) in the Medical Or Nursing Services industry is somewhat better than the same rating for OPCH (65) in the null industry. This means that CHE’s stock grew somewhat faster than OPCH’s over the last 12 months.
| CHE | OPCH | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 64% | 2 days ago 67% |
| Stochastic ODDS (%) | 2 days ago 51% | 2 days ago 60% |
| Momentum ODDS (%) | 2 days ago 49% | 2 days ago 62% |
| MACD ODDS (%) | 2 days ago 55% | 2 days ago 51% |
| TrendWeek ODDS (%) | 2 days ago 52% | 2 days ago 63% |
| TrendMonth ODDS (%) | 2 days ago 53% | 2 days ago 66% |
| Advances ODDS (%) | 2 days ago 50% | 2 days ago 60% |
| Declines ODDS (%) | 9 days ago 49% | 17 days ago 65% |
| BollingerBands ODDS (%) | N/A | 2 days ago 63% |
| Aroon ODDS (%) | 2 days ago 33% | 2 days ago 71% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CHE’s FA Score shows that 2 FA rating(s) are green while OPCH’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CHE’s TA Score shows that 5 TA indicator(s) are bullish while OPCH’s TA Score has 6 bullish TA indicator(s).
CHE (@Hospital/Nursing Management) experienced а +3.45% price change this week, while OPCH (@Hospital/Nursing Management) price change was +0.55% for the same time period.
The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was -0.81%. For the same industry, the average monthly price growth was -7.16%, and the average quarterly price growth was +16.84%.
CHE is expected to report earnings on Oct 27, 2026.
OPCH is expected to report earnings on Nov 04, 2026.
Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| SPOG | 7.78 | 0.26 | +3.41% |
| Leverage Shares 2X Long SPOT Daily ETF (SPOG) | |||
| CWS | 68.60 | 1.25 | +1.86% |
| AdvisorShares Focused Equity ETF (CWS) | |||
| HELX | 42.59 | 0.64 | +1.53% |
| Franklin Genomic Advancements ETF (HELX) | |||
| PFFD | 17.42 | 0.20 | +1.16% |
| Global X U.S. Preferred ETF (PFFD) | |||
| SCD | 14.86 | 0.02 | +0.13% |
| LMP Capital and Income Fund | |||
A.I.dvisor indicates that over the last year, CHE has been loosely correlated with UHS. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if CHE jumps, then UHS could also see price increases.
| Ticker / NAME | Correlation To CHE | 1D Price Change % | ||
|---|---|---|---|---|
| CHE | 100% | +0.44% | ||
| UHS - CHE | 44% Loosely correlated | +0.79% | ||
| PNTG - CHE | 33% Poorly correlated | +3.55% | ||
| ENSG - CHE | 32% Poorly correlated | +1.29% | ||
| OPCH - CHE | 32% Poorly correlated | +0.32% | ||
| NHC - CHE | 23% Poorly correlated | +4.71% | ||
More | ||||
A.I.dvisor tells us that OPCH and CHE have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OPCH and CHE's prices will move in lockstep.
| Ticker / NAME | Correlation To OPCH | 1D Price Change % | ||
|---|---|---|---|---|
| OPCH | 100% | +0.32% | ||
| CHE - OPCH | 32% Poorly correlated | +0.44% | ||
| FMS - OPCH | 30% Poorly correlated | +2.74% | ||
| UHS - OPCH | 27% Poorly correlated | +0.79% | ||
| ADUS - OPCH | 26% Poorly correlated | -0.11% | ||
| CYH - OPCH | 26% Poorly correlated | +0.34% | ||
More | ||||